Urdu Translation of Revised High-Level Mobility Assessment Tool (HiMAT) in Healthy Children
Urdu Translation of Psychometric Properties Analysis of Revised High-Level Mobility Assessment Tool (HiMAT) in Healthy Children
1 other identifier
observational
80
1 country
1
Brief Summary
The ability to move with ease is labelled as mobility. Limitations in mobility are frequent, recovery of these skills is crucial for physical performance which gives children valuable social possibilities and has long-term advantages for their physical and mental health. The high-level mobility assessment tool (HiMAT) is a unidimensional performance to measure the degree of high-level mobility in traumatic brain injury patients. The revised HiMAT has been utilised recently in paediatric populations to assess clinical trial outcomes and measure high-level motor skills. Urdu translation of revised HiMAT will be executed by using forward backwards translation method. Two bilingual translators fluent in both Urdu and English languages will facilitate the researcher in the translation of the tool. This final translated version will be then tested for validity and reliability on all participants of the study. The psychometric properties of the tool will be assessed including reliability, internal consistency, and item discrimination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 12, 2025
CompletedFirst Submitted
Initial submission to the registry
May 15, 2025
CompletedFirst Posted
Study publicly available on registry
May 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 16, 2025
CompletedMay 23, 2025
May 1, 2025
2 months
May 15, 2025
May 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Revised High Level Mobility Assessment Tool (HiMAT)
HiMAT is a single dimensional inspection of high-level movability for those suffering from TBI. The revised HiMAT comprises of 8 items that evaluate (1) walk forward, (2) walk backwards, (3) walk on toes and (4) walk over obstacle, (5) running, (6) skipping, (7) hopping, and (8) bounding. HiMAT has also been used to assess mobility in children with healthy conditions or suffering from any neurological disorder
6 months
Eligibility Criteria
The sample size is 80.
You may qualify if:
- Children with age group 5-12 years
- No condition affecting mobility of children
- Able to understand and follow instruction.
- Can speak \& understand language
You may not qualify if:
- Children with visual impairments.
- Children with conditions affecting their mobility.
- Children with any history of surgery in the past one year.
- Children with any cardiorespiratory comorbidities.
- Children with muscle strain, ligament sprain or joint laxity in lower extremities.
- Cognition less than 20 on Mini Mental State Examination (MMSE).
- Children with any history of any foot deformity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Riphah International University
Lahore, Punjab Province, 54000, Pakistan
Related Publications (1)
Williams G, Pallant J, Greenwood K. Further development of the High-level Mobility Assessment Tool (HiMAT). Brain Inj. 2010;24(7-8):1027-31. doi: 10.3109/02699052.2010.490517.
PMID: 20545456BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Shazia Muheen, MS
Riphah International University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2025
First Posted
May 23, 2025
Study Start
May 12, 2025
Primary Completion
June 28, 2025
Study Completion
July 16, 2025
Last Updated
May 23, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share